Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christopher Torrance
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
PLoS ONE
Multidisciplinary
Activity of EGFR, mTOR and PI3K Inhibitors in an Isogenic Breast Cell Line Model
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Synthetic Lethal Therapy for KRAS Mutant Non-Small-Cell Lung Carcinoma With Nanoparticle-Mediated CDK4 siRNA Delivery
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Allosteric Inhibitors Target KRAS in a Mutant-Specific Manner
Cancer Discovery
Oncology
Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models
Cancer Cell
Cancer Research
Oncology
Cell Biology
A Synthetic Lethal Approach for Compound and Target Identification in Staphylococcus Aureus
Nature Chemical Biology
Cell Biology
Molecular Biology
Detection of COPB2 as a KRAS Synthetic Lethal Partner Through Integration of Functional Genomics Screens
Oncotarget
Oncology
Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy With Topotecan for Patients With Neuroblastoma
BMC Cancer
Cancer Research
Oncology
Genetics
Coxsackievirus Type B3 Is a Potent Oncolytic Virus Against KRAS-Mutant Lung Adenocarcinoma
Molecular Therapy - Oncolytics
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Determination of Synthetic Lethal Interactions in KRAS Oncogene-Dependent Cancer Cells Reveals Novel Therapeutic Targeting Strategies
Cell Research
Cell Biology
Molecular Biology
Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
